Industry Reports

SymBio Pharmaceuticals Limited (4582) - Financial and Strategic SWOT Analysis Review

Friday, Apr 15, 2016

SymBio Pharmaceuticals Limited (SymBio) is a biopharmaceutical company that conducts research and development, and manufactures new drug candidates. The company develops drug delivery products such as transdermal patch containing granisetron for the treatment of chemotherapy induced nausea or vomiting. It offers products for use in the therapeutic areas of autoimmune, oncology and hematology diseases. SymBio offers packaging, labeling and storage services. The company offers designing and operation of clinical tests. It manufactures and markets its drugs with the help of domestic and foreign pharmaceutical companies. SymBio is headquartered in Minato-ku, Japan.

Read More>